Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

The European respiratory journal·2026
Same author

Novel regimens for treatment of <i>Mycobacterium avium</i> lung disease based on advanced <i>in vitro</i> systems and the mathematics of basis functions.

bioRxiv : the preprint server for biology·2026
Same author

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for <i>Mycobacterium abscessus</i> lung disease.

Antimicrobial agents and chemotherapy·2026
Same author

Hypertonic Saline or Carbocisteine in Bronchiectasis.

The New England journal of medicine·2026
Same author

Cystic Fibrosis Transmembrane Conductance Regulator Mutations and Potential Associations With Increased Rates of Pulmonary Infections Among Patients from the US Bronchiectasis and NTM Research Registry.

Chest·2026
Same author

Culture and real-time quantitative PCR to detect environmental nontuberculous mycobacteria in a clinical care center.

Total environment microbiology·2026

Related Experiment Video

Updated: Feb 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.9K

Bronchiectasis.

Pamela J McShane1, Gregory Tino2

  • 1Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL.

Chest
|November 8, 2018
PubMed
Summary
This summary is machine-generated.

Recent advances in bronchiectasis research offer hope for evidence-based therapies. Studies on inhaled antibiotics, macrolides, and airway clearance are improving patient outcomes for this growing lung condition.

Keywords:
airway clearancebronchiectasisinhaled antibiotics

More Related Videos

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

18.3K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.3K

Related Experiment Videos

Last Updated: Feb 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.9K
Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

18.3K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.3K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Bronchiectasis is a growing clinical syndrome with significant healthcare costs and morbidity.
  • Historically neglected therapeutically, recent advances have spurred new research and therapeutic development.
  • National registries and consensus definitions are improving the study of bronchiectasis.

Purpose of the Study:

  • To summarize recent advances in bronchiectasis research.
  • To highlight progress in understanding and treating bronchiectasis.
  • To underscore the need for further research into phenotypes and evidence-based therapies.

Main Methods:

  • Review of recent clinical trials and research studies in bronchiectasis.
  • Analysis of advancements in diagnostic techniques (e.g., 16S rRNA, whole genome sequencing).
  • Examination of therapeutic interventions including inhaled antibiotics, macrolides, and airway clearance.

Main Results:

  • Inhaled antibiotic trials have shown promise in reducing exacerbation frequency.
  • Macrolide therapy has demonstrated efficacy in reducing exacerbations.
  • Research is advancing understanding of microbiological characteristics and host responses.
  • New tools for quantifying disease severity and predicting prognosis have been developed.

Conclusions:

  • Significant progress has been made in bronchiectasis research, moving towards evidence-based therapies.
  • Further research into bronchiectasis phenotypes is crucial for advancing treatment.
  • There is optimism for improved patient outcomes with continued scientific investigation.